Cartesian Therapeutics
RNAC
RNAC
84 hedge funds and large institutions have $63.3M invested in Cartesian Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 17
63% less call options, than puts
Call options by funds: $18K | Put options by funds: $48K
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
84
Holding in Top 10
–
Calls
$18K
Puts
$48K
Top Buyers
| 1 | +$2.51M | |
| 2 | +$747K | |
| 3 | +$377K | |
| 4 |
Renaissance Technologies
New York
|
+$361K |
| 5 |
Citigroup
New York
|
+$327K |
Top Sellers
| 1 | -$3.61M | |
| 2 | -$929K | |
| 3 | -$914K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$752K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$720K |